For research and educational purposes only. Not medical advice.
Pentadeca Arginate Reference
Educational, not medical advice reference for Pentadeca Arginate: Recovery; regulatory status, evidence posture, source review, and schedule not…
Reference summary
No independent PubMed-indexed human clinical or peer-reviewed preclinical data for Pentadeca Arginate specifically are published at the time of review. Marketing materials extrapolate from BPC-157 research, but the two are not the same molecule.
Regulatory and posture
- Categories
- Recovery
- Aliases
- PDA, Pentadecapeptide arginate, Arginate-salt BPC-157 analog
- Evidence posture
- preclinical - No independent peer-reviewed human or preclinical data published for Pentadeca Arginate itself. Claims extrapolate from BPC-157 research.
- Regulatory status
- No FDA-approved Pentadeca Arginate drug label. PDA is a newer community compound marketed as a salt-stabilized analog of BPC-157. It lacks independent peer-reviewed human clinical evidence.
- Content review status
- research reference
Selected public sources
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.